Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 370

Similar articles for PubMed (Select 15585386)

1.

Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.

Sihvo EI, Räsänen JV, Knuuti MJ, Minn HR, Luostarinen ME, Viljanen T, Färkkilä MA, Salo JA.

J Gastrointest Surg. 2004 Dec;8(8):988-96.

PMID:
15585386
2.

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

Räsänen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, Viljanen T, Salo JA.

Ann Surg Oncol. 2003 Oct;10(8):954-60.

PMID:
14527917
3.

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.

J Clin Oncol. 2000 Sep 15;18(18):3202-10.

PMID:
10986052
4.

Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.

Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.

Int J Surg. 2007 Dec;5(6):399-403. Epub 2007 Jun 3.

5.

Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.

Keswani RN, Early DS, Edmundowicz SA, Meyers BF, Sharma A, Govindan R, Chen J, Kohlmeier C, Azar RR.

Gastrointest Endosc. 2009 Jun;69(7):1210-7. doi: 10.1016/j.gie.2008.08.016. Epub 2008 Nov 13.

PMID:
19012886
6.

The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.

Cancer. 2005 Jan 1;103(1):148-56.

7.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
8.

Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.

Sandha GS, Severin D, Postema E, McEwan A, Stewart K.

Gastrointest Endosc. 2008 Mar;67(3):402-9. doi: 10.1016/j.gie.2007.09.006.

PMID:
18178202
9.

The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.

Pfau PR, Perlman SB, Stanko P, Frick TJ, Gopal DV, Said A, Zhang Z, Weigel T.

Gastrointest Endosc. 2007 Mar;65(3):377-84.

PMID:
17321235
10.
12.

Role of positron emission tomography in the (re-)staging of oesophageal cancer.

Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.

Scand J Gastroenterol Suppl. 2006;(243):116-22. Review.

PMID:
16782630
13.

Detection of distant metastases in esophageal cancer with (18)F-FDG PET.

Heeren PA, Jager PL, Bongaerts F, van Dullemen H, Sluiter W, Plukker JT.

J Nucl Med. 2004 Jun;45(6):980-7.

14.

Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.

Salahudeen HM, Balan A, Naik K, Mirsadraee S, Scarsbrook AF.

Clin Radiol. 2008 Jul;63(7):765-73. doi: 10.1016/j.crad.2008.02.002. Epub 2008 Apr 11.

PMID:
18555034
15.

[Positron emission tomography for the preoperative staging of esophageal carcinoma].

Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.

Dtsch Med Wochenschr. 2002 Sep 20;127(38):1935-41. German.

PMID:
12239652
16.

Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.

Lowe VJ, Booya F, Fletcher JG, Nathan M, Jensen E, Mullan B, Rohren E, Wiersema MJ, Vazquez-Sequeiros E, Murray JA, Allen MS, Levy MJ, Clain JE.

Mol Imaging Biol. 2005 Nov-Dec;7(6):422-30.

PMID:
16270235
17.

[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].

Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.

Chirurg. 2003 Oct;74(10):922-30; discussion 929-30. German.

PMID:
14605734
18.

Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters.

Roedl JB, Blake MA, Holalkere NS, Mueller PR, Colen RR, Harisinghani MG.

Abdom Imaging. 2009 Sep-Oct;34(5):610-7. doi: 10.1007/s00261-008-9447-x.

PMID:
18830663
19.

The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.

Berrisford RG, Wong WL, Day D, Toy E, Napier M, Mitchell K, Wajed S.

Eur J Cardiothorac Surg. 2008 Jun;33(6):1112-6. doi: 10.1016/j.ejcts.2008.01.055. Epub 2008 Mar 6.

PMID:
18328726
20.

Role of FDG-PET in the assessment of survival prognosis in melanoma.

Pleiss C, Risse JH, Biersack HJ, Bender H.

Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.

PMID:
18158764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk